The first case of Candida dubliniensis endophthalmitis in North America

Wiwanitkit, Somsri; Wiwanitkit, Viroj

doi:10.1007/s10792-012-9662-x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This case was initially thought to represent the first case of C. dubliniensis endophthlamitis in North America, but a letter to the editor sent by Wiwanitkit revealed that the first case was indeed the one discussed above, rendering the case by Espinosa-Heidmann et al second on the list [20]. This case concerned a 27-year-old white male with a history of intravenous drug use as his only risk factor, and onychomycosis as the suspected source of infection [16].…”

Section: Discussionmentioning

confidence: 97%

Third case of Candida dubliniensis endogenous endophthalmitis in North America: case report and review of the literature

et al. 2013

View full text Add to dashboard Cite

There are two previous reports of Candida dubliniensis endophthalmitis in North America. Here, we report a third case of C. dubliniensis endogenous endophthalmitis in a 31-year-old male patient who complained of left-sided decreased visual acuity. He had an associated mitral and tricuspid valve endocarditis, in the setting of intravenous drug use. Blood and sputum cultures were positive for C. dubliniensis. Fundoscopic examination was consistent with a fungal endophthalmitis. He was treated with fluconazole followed by intravenous liposomal amphotericin B for 6 weeks. C. dubliniensis is an important but rare cause of endophthalmitis in intravenous drug abusers.

show abstract

Section: Discussionmentioning

confidence: 97%